ENTRY       D00690                      Drug
NAME        Mometasone furoate (JAN/USP);
            Asmanex (TN);
            Elocon (TN)
PRODUCT     ASMANEX (Organon LLC)
            ASMANEX HFA (Organon LLC)
            SINUVA (Intersect ENT)
  GENERIC   MOMETASONE FUROATE (A-S Medication Solutions)
            MOMETASONE FUROATE (A-S Medication Solutions)
            MOMETASONE FUROATE (A-S Medication Solutions)
            MOMETASONE FUROATE (Amneal Pharmaceuticals LLC)
            MOMETASONE FUROATE (Apotex Corp.)
            MOMETASONE FUROATE (Bryant Ranch Prepack)
            MOMETASONE FUROATE (Bryant Ranch Prepack)
            MOMETASONE FUROATE (Bryant Ranch Prepack)
            MOMETASONE FUROATE (Bryant Ranch Prepack)
            MOMETASONE FUROATE (Bryant Ranch Prepack)
            MOMETASONE FUROATE (Bryant Ranch Prepack)
            MOMETASONE FUROATE (Bryant Ranch Prepack)
            MOMETASONE FUROATE (Bryant Ranch Prepack)
            MOMETASONE FUROATE (Bryant Ranch Prepack)
            MOMETASONE FUROATE (Cosette Pharmaceuticals)
            MOMETASONE FUROATE (Cosette Pharmaceuticals)
            MOMETASONE FUROATE (E. Fougera & Co. a division of Fougera Pharmaceuticals)
            MOMETASONE FUROATE (E. Fougera & Co. a division of Fougera Pharmaceuticals)
            MOMETASONE FUROATE (E. Fougera & Co. a division of Fougera Pharmaceuticals)
            MOMETASONE FUROATE (Glenmark Pharmaceuticals)
            MOMETASONE FUROATE (Glenmark Pharmaceuticals)
            MOMETASONE FUROATE (Glenmark Pharmaceuticals)
            MOMETASONE FUROATE (Golden State Medical Supply)
            MOMETASONE FUROATE (NORTHSTAR RX LLC)
            MOMETASONE FUROATE (Padagis Israel Pharmaceuticals)
            MOMETASONE FUROATE (Padagis Israel Pharmaceuticals)
            MOMETASONE FUROATE (Padagis Israel Pharmaceuticals)
            MOMETASONE FUROATE (Preferred Pharmaceuticals)
            MOMETASONE FUROATE (Preferred Pharmaceuticals)
            MOMETASONE FUROATE (Proficient Rx LP)
            MOMETASONE FUROATE (Proficient Rx LP)
            MOMETASONE FUROATE (Proficient Rx LP)
            MOMETASONE FUROATE (REMEDYREPACK)
            MOMETASONE FUROATE (RPK Pharmaceuticals)
            MOMETASONE FUROATE (RPK Pharmaceuticals)
            MOMETASONE FUROATE (Taro Pharmaceuticals U.S.A.)
            MOMETASONE FUROATE (Taro Pharmaceuticals U.S.A.)
            MOMETASONE FUROATE (Taro Pharmaceuticals U.S.A.)
            QUINIXIL (V2 Pharma)
FORMULA     C27H30Cl2O6
EXACT_MASS  520.1419
MOL_WEIGHT  521.4295
CLASS       Anti-inflammatory
             DG01955  Corticosteroid
              DG02068  Glucocorticoid
            Dermatological agent
             DG03243  Atopic dermatitis agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C07817
            Therapeutic category: 2290 2646
            ATC code: D07AC13 D07XC03 R01AD09 R03BA07
            Chemical structure group: DG00419
            Product (DG00419): D00690<JP/US> D03325<JP>
            Product (mixture): D10295<US> D11861<JP> D11862<JP> D12501<US>
EFFICACY    Antiasthmatic, Anti-inflammatory, Glucocorticoid receptor agonist
  DISEASE   Asthma [DS:H00079]
            Seasonal allergic rhinitis [DS:H01360]
TARGET      NR3C1 (GR) [HSA:2908] [KO:K05771]
  PATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
               D07A CORTICOSTEROIDS, PLAIN
                D07AC Corticosteroids, potent (group III)
                 D07AC13 Mometasone
                  D00690  Mometasone furoate (JAN/USP) &lt;JP/US&gt;
               D07X CORTICOSTEROIDS, OTHER COMBINATIONS
                D07XC Corticosteroids, potent, other combinations
                 D07XC03 Mometasone
                  D00690  Mometasone furoate (JAN/USP) &lt;JP/US&gt;
             R RESPIRATORY SYSTEM
              R01 NASAL PREPARATIONS
               R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
                R01AD Corticosteroids
                 R01AD09 Mometasone
                  D00690  Mometasone furoate (JAN/USP) &lt;JP/US&gt;
              R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
               R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
                R03BA Glucocorticoids
                 R03BA07 Mometasone
                  D00690  Mometasone furoate (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Dermatological Agents
              Dermatitis and Pruitus Agents
               Glucocorticoids, Medium Potency
                Mometasone
                 D00690  Mometasone furoate (JAN/USP)
             Respiratory Tract/Pulmonary Agents
              Anti-inflammatories, Inhaled Corticosteroids
               Mometasone
                D00690  Mometasone furoate (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              22  Respiratory organ agents
               229  Miscellaneous
                2290  Miscellaneous
                 D00690  Mometasone furoate (JAN/USP)
              26  Epidermides
               264  Analgesics, anti-itchings, astringents, anti-inflammatory agents
                2646  Adrenocorticotropic hormones
                 D00690  Mometasone furoate (JAN/USP)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01955  Corticosteroid
               DG02068  Glucocorticoid
                DG00419  Mometasone
                 D00690  Mometasone furoate
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00690  Mometasone furoate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00419  Mometasone
                 D00690  Mometasone furoate
            Drug classes [BR:br08332]
             Anti-inflammatory
              DG01955  Corticosteroid
               D00690  Mometasone furoate
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00690  Mometasone furoate
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               3-Ketosteroid receptor
                NR3C1 (GR)
                 D00690  Mometasone furoate (JAN/USP) &lt;JP/US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00690
            Topical steroids potency [br08317.html]
             Classification in the USA
              D00690
             Classification in Japan
              D00690
            Rx-to-OTC switch list in the USA [br08315.html]
             D00690
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01955  Corticosteroid
               DG02068  Glucocorticoid
                DG00419  Mometasone
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00419  Mometasone
DBLINKS     CAS: 83919-23-7
            PubChem: 7847756
            ChEBI: 47564
            PDB-CCD: MOF
            LigandBox: D00690
            NIKKAJI: J258.527H
ATOM        35
            1   C1z C    33.4094  -17.0168
            2   C1z C    32.2455  -17.6911
            3   C1y C    34.5745  -17.6967
            4   O7a O    35.2692  -15.9227
            5   C5a C    33.3979  -15.6626
            6   C1y C    32.2455  -19.0336
            7   C1x C    31.0814  -17.0111
            8   C1a C    32.2396  -16.3195
            9   C1x C    34.5676  -19.0395
            10  C1a C    35.8931  -18.0539
            11  C7a C    36.6407  -15.9227
            12  C1b C    34.5851  -14.9768
            13  O5a O    32.2109  -14.9883
            14  C1y C    31.0758  -19.7079
            15  C1y C    29.9116  -17.6852
            16  C8y C    37.3207  -14.7357
            17  O6a O    37.3207  -17.1098
            18  X   Cl   34.5736  -13.6053
            19  C1z C    29.9060  -19.0336
            20  C1x C    31.0814  -21.0563
            21  O1a O    28.7362  -16.9995
            22  C8x C    38.6969  -14.7425
            23  O2x O    36.9040  -13.4470
            24  C1z C    28.7418  -19.7079
            25  X   Cl   29.9001  -20.3763
            26  C1x C    29.9116  -21.7363
            27  C8x C    39.1183  -13.4369
            28  C8x C    38.0098  -12.6305
            29  C2y C    28.7418  -21.0620
            30  C2x C    27.5721  -19.0336
            31  C1a C    28.7303  -18.3595
            32  C2x C    27.5721  -21.7363
            33  C2x C    26.4023  -19.7079
            34  C5x C    26.4023  -21.0620
            35  O5x O    25.2268  -21.7305
BOND        39
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     1   5 1 #Up
            5     2   6 1
            6     2   7 1
            7     2   8 1 #Up
            8     3   9 1
            9     3  10 1 #Down
            10    4  11 1
            11    5  12 1
            12    5  13 2
            13    6  14 1
            14    7  15 1
            15   11  16 1
            16   11  17 2
            17   12  18 1
            18   14  19 1
            19   14  20 1
            20   15  21 1 #Up
            21   16  22 2
            22   16  23 1
            23   19  24 1
            24   19  25 1 #Down
            25   20  26 1
            26   22  27 1
            27   23  28 1
            28   24  29 1
            29   24  30 1
            30   24  31 1 #Up
            31   29  32 2
            32   30  33 2
            33   32  34 1
            34   34  35 2
            35    6   9 1
            36   15  19 1
            37   26  29 1
            38   27  28 2
            39   33  34 1
///
